CME Office: 
Series date: 
Wednesday, January 1, 2020 - 8:00am to Thursday, December 31, 2020 - 9:00am

Target Audience: Hematology Oncology & Pathology Providers

Learning Objectives:

As a result of this activity, participants will be able to:

  1. Recognize and implement a standardized approach to hematologic malignancies and malignant lymphoma with regards to diagnosis, staging and treatment.
  2. Devise multidisciplinary approach in utilizing knowledge of current and emerging diagnostic markers and assays in the diagnosis of hematologic malignancies.
  3. Apply diagnostics criteria for a variety of hematologic malignancies.
  4. Review the results from current clinical trials to determine the optimal therapies for defined patient groups with hematologic malignancies and malignant lymphoma. 

Planner: Alfredo Lopez, MD

Accreditation Statement: The Kaiser San Francisco (San Francisco, CA 94115) is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians.

Credit Designation: The Kaiser San Francisco (San Francisco, CA 94115) designates this Live Activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement: The faculty and planners for this activity, as well as the CME staff, do not have any relevant financial relationships with commercial interests or affiliations to disclose.

Series location: 
350 St. Joseph
Pathology Conference Room
San Francisco, CA
United States

Sessions